Clinical evidence synthesis largely relies on systematic reviews (SR) of clinical studies from medical literature. Here, we propose a generative artificial intelligence (AI) pipeline named TrialMind to streamline study search, study screening, and data…
Continue Reading
OpenEvidence, an AI-enabled medical research aggregate platform for doctors, has closed a Series A funding round with Sequoia Capital, boosting its valuation to $1 billion and bringing its total raise to more than $100…
Continue Reading
Cofactor AI, a company that helps hospitals appeal claims denials, announced it raised $4 million in a seed funding round led by Drive Capital. WHAT IT DOES
Cofactor AI’s platform, Cofactor Denial Suite, combines with EHR…
Jennifer Goldsack, CEO, Digital Medicine Society (DiMe)
Dr. Shubs Upadhyay, Director of Medical Quality, Ada Health
Lucy Orr-Ewing, Chief of Staff and Head of Policy, Coalition for Health AI (CHAI)
As the digital health market continues to…
Continue Reading
Accelerating clinical evidence generation is one of the most important steps the healthcare industry can take to advance personalized treatment, Amy Abernethy declared in an interview this week.
“When I talk about clinical evidence generation,…
Continue Reading
